Acurx Pharmaceuticals Inc (ACXP) Down 5.00% in Premarket Trading

Acurx Pharmaceuticals Inc (ACXP) has fallen Friday morning, with the stock decreasing -5.00% in pre-market trading to 3.61. ACXP's short-term technical score of 21 indicates that the stock has traded less bullishly over the last month than 79% of stocks on the market. In the Biotechnology industry, which ranks 131 out of 146 industries, ACXP ranks higher than 38% of stocks. Acurx Pharmaceuticals Inc has risen 196.88% over the past month, closing at $1.92 on October 6. During this period of time, the stock fell as low as $1.92 and as high as $8.82. ACXP has an average analyst recommendation of Strong Buy. The company has an average price target of $11.50.

ACXP has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on ACXP!

See Full ACXP Report

Acurx Pharmaceuticals Inc has a Long-Term Technical rank of 98. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 2% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, ACXP ranks better than 132% of stocks.

Important Dates for Investors in ACXP:

-Acurx Pharmaceuticals Inc is set to release earnings on 2023-11-14. Over the last 12 months, the company has reported EPS of $-1.13. -We do not have a set dividend date for Acurx Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Acurx Pharmaceuticals Inc (ACXP)